MDL 63246

Known as: MDL 63,246, MDL-63,246, MDL-63246 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2007
012319952007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The emergence of resistance among Gram-positive pathogens towards glycopeptide antibiotics has stimulated the research of second… (More)
Is this relevant?
Review
2002
Review
2002
Biosearch Italia and Versicor are developing dalbavancin, a novel semisynthetic derivative of the natural glycopeptide A-40926… (More)
Is this relevant?
1995
1995
MDL 63,246 is a semisynthetic derivative of the naturally occurring glycopeptide antibiotic MDL 62,476 (A40926). It was more… (More)
Is this relevant?
1995
1995
The in vitro activity of the semisynthetic glycopeptide amide MDL 63,246 against 293 U.S. clinical isolates of gram-positive… (More)
Is this relevant?
1995
1995
Following intravenous administration in the rat, the concentration of MDL 63,246 in plasma was high and long-lasting… (More)
Is this relevant?